PubMed

Intrinsic bias in breast cancer gene expression data sets.

Mosley JD, Keri RA.

BMC Cancer. 2009 Jun 29;9:214.PMID: 19563679 [PubMed - in process]Related articlesFree article

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF.

Clin Cancer Res. 2003 Jul;9(7):2406-15.PMID: 12855612 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.PMID: 16673249 [PubMed - indexed for MEDLINE]Related articles

The molecular portraits of breast tumors are conserved across microarray platforms.

Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM.

BMC Genomics. 2006 Apr 27;7:96.PMID: 16643655 [PubMed - indexed for MEDLINE]Related articlesFree article

Challenges in projecting clustering results across gene expression-profiling datasets.

Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.PMID: 18000217 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.

Rody A, Karn T, Ruckhäberle E, Müller V, Gehrmann M, Solbach C, Ahr A, Gätje R, Holtrich U, Kaufmann M.

Breast Cancer Res Treat. 2009 Feb;113(3):457-66. Epub 2008 Mar 14.PMID: 18340528 [PubMed - indexed for MEDLINE]Related articles

Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.

Yang F, Foekens JA, Yu J, Sieuwerts AM, Timmermans M, Klijn JG, Atkins D, Wang Y, Jiang Y.

Oncogene. 2006 Mar 2;25(9):1413-9.PMID: 16261164 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.PMID: 18662380 [PubMed - indexed for MEDLINE]Related articlesFree article

Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.

Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.

BMC Bioinformatics. 2008 Jan 28;9:63.PMID: 18226260 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.

Korkola JE, Blaveri E, DeVries S, Moore DH 2nd, Hwang ES, Chen YY, Estep AL, Chew KL, Jensen RH, Waldman FM.

BMC Cancer. 2007 Apr 11;7:61.PMID: 17428335 [PubMed - indexed for MEDLINE]Related articlesFree article

Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists.

Mosley JD, Keri RA.

BMC Med Genomics. 2008 Apr 25;1:11.PMID: 18439262 [PubMed]Related articlesFree article

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J.

Breast Cancer Res. 2007;9(1):R16.PMID: 17263897 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

Martin KJ, Patrick DR, Bissell MJ, Fournier MV.

PLoS One. 2008 Aug 20;3(8):e2994.PMID: 18714348 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.

J Clin Oncol. 2006 Apr 10;24(11):1656-64. Epub 2006 Feb 27.PMID: 16505416 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression signature of estrogen receptor alpha status in breast cancer.

Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM.

BMC Genomics. 2005 Mar 11;6(1):37.PMID: 15762987 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.

Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE.

Cancer. 1994 Sep 1;74(5):1575-83.PMID: 7914825 [PubMed - indexed for MEDLINE]Related articles

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.

Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.

J Clin Oncol. 2006 Sep 10;24(26):4245-53.PMID: 16963728 [PubMed - indexed for MEDLINE]Related articles

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K.

BMC Cancer. 2008 Sep 8;8:254.PMID: 18778486 [PubMed - indexed for MEDLINE]Related articlesFree article

A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

Yu K, Ganesan K, Miller LD, Tan P.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3288-96.PMID: 16740749 [PubMed - indexed for MEDLINE]Related articlesFree article